ADViRNA
Biotechnology ResearchMassachusetts, United States2-10 Employees
Advirna is a private biotechnology company at the forefront of developing innovative solutions for the efficient delivery of polynucleotides. Our proprietary technology platform, self-deliverable RNAi, leverages the groundbreaking discovery of RNA interference (RNAi) to specifically regulate gene activity within living cells. With a focus on therapeutic siRNAs and antisense oligonucleotides, Advirna revolutionizes gene silencing and therapeutic targeting. Our custom-designed algorithms generate potent and highly targeted siRNAs, ensuring maximum efficacy and specificity. We excel in creating bespoke assays to assess siRNA targeting specificity and potency, measuring both protein and gene expression values with precision. Advirna’s capabilities extend beyond in vitro experiments, as we organize and support comprehensive in vivo studies to validate the therapeutic potential of our oligonucleotides. Our expert team offers consulting services, helping clients navigate various experimental approaches and optimize their experimental designs. At Advirna, we are committed to advancing the field of RNA therapeutics, providing cutting-edge solutions to address complex genetic disorders and enhance human health. Join us on our mission to harness the power of RNAi and transform the future of medicine. Schedule a consultation with us! https://calendly.com/advirna/consultation
1-888-653-2347 
support@leadiq.com 
